Literature DB >> 20951826

Metabolic physiology in age related macular degeneration.

Einar Stefánsson1, Asbjörg Geirsdóttir, Haraldur Sigurdsson.   

Abstract

Ischemia and hypoxia have been implicated in the pathophysiology of age related macular degeneration (AMD). This has mostly been based on studies on choroidal perfusion, which is not the only contributor to retinal hypoxia found in AMD eyes. Other features of AMD may also interfere with retinal oxygen metabolism including confluent drusen, serous or hemorrhagic retinal detachment, retinal edema and vitreoretinal adhesion. Each of these features contributes to retinal hypoxia: the drusen and retinal elevation by increasing the distance between the choriocapillaris and retina; vitreoretinal adhesion by reducing diffusion and convection of oxygen towards and vascular endothelial growth factor (VEGF) away from hypoxic retinal areas. Hypoxia-inducible-factor is known to exist in subretinal neovascularization and hypoxia is the main stimulus for the production of VEGF. Each feature may not by itself create enough hypoxia and VEGF accumulation to stimulate wet AMD, but they may combine to do so. Choroidal ischemia in AMD has been demonstrated by many researchers, using different technologies. Choroidal ischemia obviously decreases oxygen delivery to the outer retina. Confluent drusen, thickening of Bruch's membrane and any detachment of retina or retinal pigment epithelium, increases the distance between the choriocapillaris and the retina and thereby reduces the oxygen flux from the choroid to the outer retina according to Fick's law of diffusion. Retinal elevation and choroidal ischemia may combine forces to reduce choroidal oxygen delivery to the outer retina, produce retinal hypoxia. Hypoxia leads to production of VEGF leading to neovascularization and tissue edema. A vicious cycle may develop, where VEGF production increases effusion, retinal detachment and edema, further increasing hypoxia and VEGF production. Adhesion of the viscous posterior vitreous cortex to the retina maintains a barrier to diffusion and convection currents in the vitreous cavity according to the laws of Fick's, Stokes-Einstein and Hagen-Poiseuille. If the vitreous is detached from the surface of the retina, the low viscosity fluid transports oxygen and nutrients towards an ischemic area of the retina, and cytokines away from the retina, at a faster rate than through attached vitreous gel. Vitreoretinal adhesion can exacerbate retinal hypoxia and accumulation of cytokines, such as VEGF. Vitreoretinal traction can also cause hypoxia by retinal elevation. Conceivably, the basic features of AMD, drusen, choroidal ischemia, and vitreoretinal adhesion are independently determined by genetics and environment and may combine in variable proportions. If the resulting hypoxia and consequent VEGF accumulation crosses a threshold, this will trigger effusion and neovascularization. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20951826     DOI: 10.1016/j.preteyeres.2010.09.003

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  44 in total

1.  Branch retinal vein occlusion and vitreovascular traction: a preliminary spectral domain OCT case-control study.

Authors:  Francisco J Ascaso; Esteban Padgett; Esther Núñez; Laura Villén; Andrzej Grzybowski; José A Cristóbal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03       Impact factor: 3.117

Review 2.  The expanding role of vascular endothelial growth factor inhibitors in ophthalmology.

Authors:  Michael W Stewart
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

3.  Quantitative assessment of choriocapillaris flow deficits in eyes with macular neovascularization.

Authors:  Federico Corvi; Mariano Cozzi; Giulia Corradetti; Giovanni Staurenghi; David Sarraf; SriniVas R Sadda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-08       Impact factor: 3.117

4.  Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.

Authors:  Saida Omarova; Casey D Charvet; Rachel E Reem; Natalia Mast; Wenchao Zheng; Suber Huang; Neal S Peachey; Irina A Pikuleva
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

Review 5.  The role of epigenetics in age-related macular degeneration.

Authors:  M Gemenetzi; A J Lotery
Journal:  Eye (Lond)       Date:  2014-09-19       Impact factor: 3.775

Review 6.  Retinal oxygen: from animals to humans.

Authors:  Robert A Linsenmeier; Hao F Zhang
Journal:  Prog Retin Eye Res       Date:  2017-01-18       Impact factor: 21.198

Review 7.  Topographical control of ocular cell types for tissue engineering.

Authors:  Kevin J McHugh; Magali Saint-Geniez; Sarah L Tao
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2013-06-07       Impact factor: 3.368

8.  O2-controllable hydrogels for studying cellular responses to hypoxic gradients in three dimensions in vitro and in vivo.

Authors:  Daniel M Lewis; Michael R Blatchley; Kyung Min Park; Sharon Gerecht
Journal:  Nat Protoc       Date:  2017-07-20       Impact factor: 13.491

9.  Hypoxia alters ocular drug transporter expression and activity in rat and calf models: implications for drug delivery.

Authors:  Rajendra S Kadam; Preveen Ramamoorthy; Daniel J LaFlamme; Timothy A McKinsey; Uday B Kompella
Journal:  Mol Pharm       Date:  2013-05-22       Impact factor: 4.939

10.  Effects of VEGF levels on anti-VEGF therapy for patients with idiopathic choroidal neovascularization.

Authors:  Xiaojuan Fan; Ning Gao; Jingming Li; Jianqin Lei; Qianyan Kang
Journal:  Mol Cell Biochem       Date:  2017-09-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.